BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 19200645)

  • 1. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bilateral inferior petrosal sinus sampling in the diagnosis and surgical treatment of the ACTH-dependent Cushing's syndrome: a comparison with other tests.
    Shi X; Sun Q; Bian L; Zhao W; Shen J; Wang W; Ning G
    Neuro Endocrinol Lett; 2011; 32(6):865-73. PubMed ID: 22286783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
    Dehdashti AR; Gentili F
    Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
    Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
    Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
    Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
    Kelly DF
    Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
    Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
    Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.
    Patil CG; Lad SP; Harsh GR; Laws ER; Boakye M
    Neurosurg Focus; 2007; 23(3):E7. PubMed ID: 17961019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cavernous sinus sampling in selected cases of Cushing's disease.
    Flitsch J; Lüdecke DK; Knappe UJ; Grzyska U
    Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):329-35. PubMed ID: 12397531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative MRI for transphenoidal procedures: short-term outcome for 100 consecutive cases.
    Vitaz TW; Inkabi KE; Carrubba CJ
    Clin Neurol Neurosurg; 2011 Nov; 113(9):731-5. PubMed ID: 21889838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
    Estrada J; Boronat M; Mielgo M; Magallón R; Millan I; Díez S; Lucas T; Barceló B
    N Engl J Med; 1997 Jan; 336(3):172-7. PubMed ID: 8988897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cushing disease: long-term follow-up after transsphenoidal surgery].
    Benbassat CA; Tsvetov G; Shefet D; Weinstein R; Rappaport ZH
    Harefuah; 2004 Sep; 143(9):636-8, 696, 695. PubMed ID: 15521676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
    Czirják S; Bezzegh A; Gál A; Rácz K
    Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases.
    Höybye C; Grenbäck E; Thorén M; Hulting AL; Lundblad L; von Holst H; Anggård A
    J Neurosurg; 2004 Apr; 100(4):634-8. PubMed ID: 15070117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: outcomes with Cushing's disease.
    Sarkar S; Rajaratnam S; Chacko G; Mani S; Hesargatta AS; Chacko AG
    Acta Neurochir (Wien); 2016 Jan; 158(1):77-86; discussion 86. PubMed ID: 26577636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.